Swissmedic is the regulatory agency responsible for authorizing and supervising therapeutic products in Switzerland. Based in Bern, the agency started its activities on 1 January 2012, replacing the Interkantonale Kontrollstelle für Heilmittel (IKS). It was created by the Federal Act on Medicinal Products and Medical Devices and is attached to the Federal Department of Home Affairs, but functions as a autonomous agency with its own budget.
Swissmedic is responsible for the authorization of health products, and for licensing their manufacturing and wholesale. It also deals with clinical trials, establishing standards, and monitoring these products on the market.
Swissmedic’s organizational structure is made up of 4 departments:
A list of European regulations can be found here on our website.
Contact details:
Medical Device Associations in Switzerland:
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多自2022年5月26日始,欲在欧盟(EU)上市的新型体外诊断(IVD)医疗器械必须符合欧盟体外诊断医疗器械法规(2017/746 IVDR)。 同日起,带有有效CE标志的IVD可以继续按照指令98/79/EC(IVDD)进行销售,直至其许可证到期为止。 自2025年5月27日始,在欧盟销售的所
阅读更多